PortfoliosLab logoPortfoliosLab logo
CVRx, Inc. (CVRX)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US1266381052
CUSIP
126638105
IPO Date
Jun 30, 2021

Highlights

Market Cap
$248.02M
Enterprise Value
$223.11M
EPS (TTM)
-$2.04
Total Revenue (TTM)
$56.65M
Gross Profit (TTM)
$48.34M
EBITDA (TTM)
-$47.59M
Year Range
$4.30 - $12.70
Target Price
$11.50
ROA (TTM)
-50.87%
ROE (TTM)
-135.56%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CVRx, Inc.

Often compared with CVRX:
CVRX vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in CVRx, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

CVRx, Inc. (CVRX) has returned 33.24% so far this year and -22.65% over the past 12 months.


CVRx, Inc.

1D
6.77%
1M
15.93%
YTD
33.24%
6M
17.22%
1Y
-22.65%
3Y*
0.50%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 30, 2021, CVRX's average daily return is +0.09%, while the average monthly return is +1.41%. At this rate, your investment would double in approximately 4.1 years.

Historically, 44% of months were positive and 56% were negative. The best month was Jun 2024 with a return of +72.5%, while the worst month was May 2024 at -55.2%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.

On a daily basis, CVRX closed higher 48% of trading days. The best single day was Jun 5, 2024 with a return of +33.9%, while the worst single day was Feb 21, 2023 at -58.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-3.52%19.12%15.93%33.24%
202526.12%-18.90%-5.63%-40.15%-9.36%-11.38%35.37%-1.38%2.80%26.27%-3.73%-27.62%-43.96%
2024-20.10%-21.86%-7.23%-14.83%-55.19%72.52%-28.69%15.32%-10.65%48.92%16.77%-17.30%-59.70%
2023-17.17%-26.84%-16.19%24.89%7.56%23.32%16.13%-3.23%-12.56%-11.80%52.99%53.59%71.34%
2022-32.13%5.78%-31.78%4.01%-0.32%-3.22%46.92%-17.89%28.69%8.04%32.74%37.14%50.04%
2021-29.50%-3.44%-13.22%2.24%-31.52%5.61%-56.32%

Benchmark Metrics

CVRx, Inc. has an annualized alpha of 6.57%, beta of 1.55, and R² of 0.09 versus S&P 500 Index. Calculated based on daily prices since July 01, 2021.

  • This stock participated in 167.43% of S&P 500 Index downside but only 51.44% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.09 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
6.57%
Beta
1.55
0.09
Upside Capture
51.44%
Downside Capture
167.43%

Return for Risk

Risk / Return Rank

CVRX ranks 34 for risk / return — below 34% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


CVRX Risk / Return Rank: 3434
Overall Rank
CVRX Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
CVRX Sortino Ratio Rank: 3838
Sortino Ratio Rank
CVRX Omega Ratio Rank: 4141
Omega Ratio Rank
CVRX Calmar Ratio Rank: 2828
Calmar Ratio Rank
CVRX Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for CVRx, Inc. (CVRX) and compare them to a chosen benchmark (S&P 500 Index).


CVRXBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.23

0.90

-1.13

Sortino ratio

Return per unit of downside risk

0.40

1.39

-0.99

Omega ratio

Gain probability vs. loss probability

1.06

1.21

-0.15

Calmar ratio

Return relative to maximum drawdown

-0.38

1.40

-1.78

Martin ratio

Return relative to average drawdown

-0.58

6.61

-7.19

Explore CVRX risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


CVRx, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the CVRx, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the CVRx, Inc. was 85.64%, occurring on Feb 17, 2026. The portfolio has not yet recovered.

The current CVRx, Inc. drawdown is 71.34%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-85.64%Dec 29, 2023534Feb 17, 2026
-83.21%Jul 1, 2021201Apr 18, 2022425Dec 26, 2023626
-0.93%Dec 27, 20231Dec 27, 20231Dec 28, 20232

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of CVRx, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how CVRx, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CVRX relative to other companies in the Medical Devices industry. Currently, CVRX has a P/S ratio of 4.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CVRX in comparison with other companies in the Medical Devices industry. Currently, CVRX has a P/B value of 6.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items